Terumo pays $2.6 billion for US blood-processing firm

Japanese firms continue on the M&A trail with Terumo entering a $2.6 billion deal to buy US blood-processing technologies company CaridianBCT from its Swedish owners.

Terumo Medical Corporation has bought CaridianBCT for $2.63 billion, in the latest of a series of cross-border acquisitions by Japanese healthcare firms.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media